Company intelligence / Profile preview

ESC Advisors

Ownership: Private
Development stage: Other

Overview

ESC Advisors is a boutique healthcare investment bank focused on the life sciences sector, providing advisory services related to financings and M&A for emerging growth and mid-cap companies in the US and Europe. It does not develop drugs or own a clinical pipeline, but advises companies operating in areas such as central nervous system, microbiome, immune system, and aging, as well as underlying technologies like immune-therapies, gene therapies, and cell therapies[1].

Industry: Consulting

Beyond the preview

Go deeper on ESC Advisors.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ESC Advisors.

Explore the full profile